Nuvectis Pharma Announces FDA Clearance of NXP900 IND
Fort Lee, NJ, May 15, 2023 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis”…
Fort Lee, NJ, May 15, 2023 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis”…
9 subjects enrolled into the OPMD clinical development program HAYWARD, Calif., May 15, 2023 (GLOBE…
SAN FRANCISCO, May 15, 2023 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…
Company to host Investor Update call on June 14, 2023 to review and discuss the…
BOTHELL, Wash., May 15, 2023 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the…
Led by Marshall Wace with participation from OrbiMed, Rosalind, Nantahala, Soleus, Velan and certain InspireMD Board members…
Shockwave C2+ Catheter Expands Utility of IVL in Calcified Coronary Arteries SANTA CLARA, Calif., May…
SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) — Locanabio, Inc., a genetic medicines company developing…
End-of-Phase 2 Meeting with FDA Anticipated in 2H 2023 to Confirm Phase 3 Regulatory Path…
Consolidated Net Revenue of $13.5 Million Up 14% vs. First Quarter of 2022 Global End…
Lead targeted oncology program in Hippo pathway, IK-930, continues to advance through dose escalation with…
– Initiated CHORD™, a global Phase 1/2 dose escalation clinical trial of lead gene therapy…
BOSTON, May 15, 2023 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”, “Company”), a targeted…
COPENHAGEN, Denmark, May 15, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today that it…
POINT further strengthens supply chain with $10 million investment in Ionetix Alpha Corp. INDIANAPOLIS and…
Updated data from VERSATILE-002 Phase 2 trial to be presented at ASCO 2023 Company to…
PALO ALTO, Calif., May 15, 2023 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”…
U.S. FDA granted Fast Track designation for 177Lu-PNT2002 for the treatment of mCRPC in April…
― Appointed Alex C. Sapir CEO & President, effective July 1st, 2023 ― ― On…
~ uniQure to receive $375 million upfront cash payment ~ ~ Under the existing agreement…